McKesson Co. (NYSE:MCK) – Equities research analysts at Jefferies Financial Group issued their Q1 2020 EPS estimates for shares of McKesson in a research note issued on Thursday, May 23rd. Jefferies Financial Group analyst B. Tanquilut anticipates that the company will earn $3.08 per share for the quarter. Jefferies Financial Group also issued estimates for McKesson’s Q2 2020 earnings at $3.65 EPS, Q3 2020 earnings at $3.45 EPS, Q4 2020 earnings at $4.02 EPS, FY2020 earnings at $14.20 EPS and FY2021 earnings at $15.25 EPS.

A number of other research analysts have also recently issued reports on MCK. ValuEngine raised shares of McKesson from a “strong sell” rating to a “sell” rating in a report on Wednesday, May 8th. Zacks Investment Research raised shares of McKesson from a “sell” rating to a “hold” rating in a report on Wednesday, April 10th. Wolfe Research began coverage on shares of McKesson in a report on Tuesday, April 2nd. They issued an “outperform” rating for the company. Barclays reaffirmed a “hold” rating and issued a $130.00 price target on shares of McKesson in a report on Friday, February 1st. Finally, Deutsche Bank raised shares of McKesson from a “sell” rating to a “hold” rating and set a $175.00 price target for the company in a report on Friday, January 25th. Two analysts have rated the stock with a sell rating, eight have given a hold rating and five have issued a buy rating to the stock. McKesson currently has a consensus rating of “Hold” and a consensus price target of $134.90.

Shares of MCK opened at $129.92 on Friday. The company has a market capitalization of $24.38 billion, a price-to-earnings ratio of 9.57, a PEG ratio of 1.29 and a beta of 1.23. McKesson has a twelve month low of $106.11 and a twelve month high of $151.24. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.02 and a quick ratio of 0.58.

McKesson (NYSE:MCK) last announced its earnings results on Wednesday, May 8th. The company reported $3.69 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $3.66 by $0.03. The company had revenue of $52.43 billion during the quarter, compared to the consensus estimate of $53.14 billion. McKesson had a net margin of 0.02% and a return on equity of 29.02%. McKesson’s revenue was up 1.6% compared to the same quarter last year. During the same period last year, the firm earned $3.49 earnings per share.

The firm also recently announced a quarterly dividend, which will be paid on Monday, July 1st. Investors of record on Monday, June 3rd will be issued a dividend of $0.39 per share. The ex-dividend date is Friday, May 31st. This represents a $1.56 annualized dividend and a dividend yield of 1.20%. McKesson’s dividend payout ratio (DPR) is presently 11.50%.

In related news, EVP Lori A. Schechter sold 2,766 shares of the firm’s stock in a transaction on Friday, May 10th. The shares were sold at an average price of $133.59, for a total transaction of $369,509.94. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.87% of the company’s stock.

Institutional investors have recently modified their holdings of the stock. Norges Bank purchased a new position in shares of McKesson during the fourth quarter worth $215,791,000. Standard Life Aberdeen plc grew its position in shares of McKesson by 16.7% in the fourth quarter. Standard Life Aberdeen plc now owns 288,482 shares of the company’s stock valued at $32,039,000 after purchasing an additional 41,289 shares during the period. Northern Trust Corp grew its position in shares of McKesson by 1.3% in the fourth quarter. Northern Trust Corp now owns 2,369,712 shares of the company’s stock valued at $261,783,000 after purchasing an additional 30,134 shares during the period. Segall Bryant & Hamill LLC grew its position in shares of McKesson by 7.5% in the fourth quarter. Segall Bryant & Hamill LLC now owns 2,861 shares of the company’s stock valued at $316,000 after purchasing an additional 200 shares during the period. Finally, BlackRock Inc. grew its position in shares of McKesson by 2.3% in the fourth quarter. BlackRock Inc. now owns 15,773,706 shares of the company’s stock valued at $1,742,522,000 after purchasing an additional 358,982 shares during the period. 85.88% of the stock is owned by hedge funds and other institutional investors.

About McKesson

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.

Further Reading: Percentage Gainers

Earnings History and Estimates for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.